Evidence map›Paper›PMID 42211507›Full record

ArticleFrontiers in oncology2026

Urinary DNA methylation biomarkers for bladder cancer diagnosis: a single center case-control study.

Chao Li, Rongjin Fang, Jiqian Wang, Yongchao Wang, Songtao Zhao, Qinglong Wu, Chen Ying, Minghuang Rao

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chao LiDepartment of Urology, Xiamen Haicang Hospital, Xiamen, Fujian, China.
Rongjin FangDepartment of Urology, Xiamen Haicang Hospital, Xiamen, Fujian, China.
Jiqian WangDepartment of Urology, Xiamen Haicang Hospital, Xiamen, Fujian, China.
Yongchao WangDepartment of Urology, Xiamen Haicang Hospital, Xiamen, Fujian, China.
Songtao ZhaoDepartment of Urology, Xiamen Haicang Hospital, Xiamen, Fujian, China.
Qinglong WuDepartment of Urology, Xiamen Haicang Hospital, Xiamen, Fujian, China.
Chen YingDepartment of Urology, Xiamen Haicang Hospital, Xiamen, Fujian, China.
Minghuang RaoDepartment of Urology, Xiamen Haicang Hospital, Xiamen, Fujian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Noninvasive detection of bladder cancer remains challenging because many urine tests trade sensitivity for specificity. We evaluated whether a biologically grounded, complementary three-gene methylation panel measured in urine could improve diagnostic performance. Methods: We conducted a single-center 1:1 matched case-control study using clinically relevant urine samples. Urine DNA was subjected to bisulfite conversion and quantitative methylation analysis targeting three gene loci ( Results: One hundred and seventy-two subjects (86 cases and 86 controls) with a mean age of 60.24 ± 12.54 and 59.70 ± 12.75 years old were included. Conclusions: A urine-based three-gene methylation panel (

Indexed as

bladder cancerHand2TRPS1urinary DNA methylationZNF154

Identifiers

PMID42211507
PMCPMC13212143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.